A Risk-Benefit Assessment of Pharmacotherapy for Anxiety Disorders in Children and Adolescents

被引:0
|
作者
Susan M. Hawkridge
Dan J. Stein
机构
[1] University of Stellenbosch,Department of Psychiatry
来源
Drug Safety | 1998年 / 19卷
关键词
Adis International Limited; Fluoxetine; Anxiety Disorder; Imipramine; Social Phobia;
D O I
暂无
中图分类号
学科分类号
摘要
Few pharmacotherapy trials have been undertaken in young people with anxiety disorders. Of those conducted, few are placebo-controlled or blinded, and often sample size is small, making interpretation of the data difficult.
引用
收藏
页码:283 / 297
页数:14
相关论文
共 50 条
  • [41] A RISK-BENEFIT ASSESSMENT OF TACROLIMUS IN TRANSPLANTATION
    WINKLER, M
    CHRISTIANS, U
    DRUG SAFETY, 1995, 12 (05) : 348 - 357
  • [42] A risk-benefit assessment of abciximab in angioplasty
    Kleiman, NS
    DRUG SAFETY, 1999, 20 (01) : 43 - 57
  • [43] A RISK-BENEFIT ASSESSMENT OF TAMOXIFEN THERAPY
    CATHERINO, WH
    JORDAN, VC
    DRUG SAFETY, 1993, 8 (05) : 381 - 397
  • [44] Clinical equipoise and risk-benefit assessment
    Miller, Franklin G.
    CLINICAL TRIALS, 2012, 9 (05) : 621 - 627
  • [45] A PRELIMINARY RISK-BENEFIT ASSESSMENT OF PACLITAXEL
    BITTON, RJ
    FIGG, WD
    REED, E
    DRUG SAFETY, 1995, 12 (03) : 196 - 208
  • [46] A risk-benefit assessment of amifostine in cytoprotection
    Mabro, M
    Faivre, S
    Raymond, E
    DRUG SAFETY, 1999, 21 (05) : 367 - 387
  • [47] A risk-benefit assessment of antileukotrienes in asthma
    Smith, LJ
    DRUG SAFETY, 1998, 19 (03) : 205 - 218
  • [48] RISK-BENEFIT ASSESSMENT OF TOCOLYTIC DRUGS
    WISCHNIK, A
    DRUG SAFETY, 1991, 6 (05) : 371 - 380
  • [49] Risk-Benefit Assessment of Carotid Revascularization
    de Oliveira, Pedro Piccaro
    da Costa Vieira, Jose Luiz
    Guimaraes, Raphael Boesche
    Almeida, Eduardo Dytz
    Savaris, Simone Louise
    Portal, Vera Lucia
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2018, 111 (04) : 618 - 625
  • [50] Study: Risk-Benefit Assessment of Food
    不详
    DEUTSCHE LEBENSMITTEL-RUNDSCHAU, 2011, 107 (03) : 108 - 109